ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,030Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 1269

$894K Total Retail Price of All Prescriptions

Rank: 36 out of 1269

573 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 573 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 573 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 12,986 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 601 524 1 1
LEVOTHYROXINE SODIUM 537 497 2 4
FUROSEMIDE 379 349 3 5
OMEPRAZOLE 376 329 4 8
GABAPENTIN 335 296 5 17
WARFARIN SODIUM 328 284 6 12
PRAVASTATIN SODIUM 314 284 7 11
AMLODIPINE BESYLATE 300 246 8 2
METOPROLOL SUCCINATE 286 262 9 13
ATORVASTATIN CALCIUM 260 221 10 7
MIRTAZAPINE 229 223 11 24
NAMENDA 190 190 12 38
DONEPEZIL HCL 190 168 12 22
SERTRALINE HCL 189 174 14 23
DIVALPROEX SODIUM 183 157 15 54
CITALOPRAM HBR 181 176 16 21
METOPROLOL TARTRATE 176 153 17 6
CARVEDILOL 161 147 18 29
LANTUS 158 122 19 39
RANITIDINE HCL 156 142 20 27
TRAZODONE HCL 155 138 21 36
LOSARTAN POTASSIUM 152 141 22 15
ISOSORBIDE MONONITRATE ER 151 144 23 63
METFORMIN HCL 149 120 24 9
DIGOXIN 142 132 25 62
HYDROCHLOROTHIAZIDE 135 128 26 10
POLYETHYLENE GLYCOL 3350 129 115 27 50
TAMSULOSIN HCL 121 109 28 31
PAROXETINE HCL 120 111 29 71
TRAMADOL HCL 119 109 30 16
BACLOFEN 118 69 31 103
ZOLPIDEM TARTRATE 117 70 32 19
KLOR-CON M20 112 111 33 60
CIPROFLOXACIN HCL 107 97 34 66
SIMVASTATIN 107 92 34 3
QUETIAPINE FUMARATE 106 104 36 53
POTASSIUM CHLORIDE 105 81 37 26
PREDNISONE 104 96 38 45
AZITHROMYCIN 103 92 39 42
IPRATROPIUM-ALBUTEROL 96 87 40 86
LEVETIRACETAM 93 88 41 55
ATENOLOL 93 89 41 14
NOVOLOG 92 62 43 82
LIDODERM 91 73 44 56
FAMOTIDINE 81 72 45 85
CLOPIDOGREL 79 65 46 32
DIOVAN 77 68 47 35
PANTOPRAZOLE SODIUM 77 65 47 18
CYMBALTA 77 43 47 70
HUMALOG 76 54 50 109
DILTIAZEM 24HR CD 76 70 50 146
CARBIDOPA-LEVODOPA 75 75 52 78
CEPHALEXIN 74 58 53 113
HYDROCODONE-ACETAMINOPHEN 72 67 S3 54 20
CLONIDINE HCL 69 48 55 51
OXYCODONE-ACETAMINOPHEN 69 45 S2 55 44
NYSTATIN 68 65 57 119
LATANOPROST 67 67 58 143
GLIMEPIRIDE 65 61 59 57
KLOR-CON 10 65 62 59 122
VENLAFAXINE HCL ER 65 53 59 140
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 52 59 33
EXELON 64 64 63 142
CRESTOR 63 58 64 25
FLUTICASONE PROPIONATE 63 53 64 40
FLUOXETINE HCL 60 54 66 83
IPRATROPIUM BROMIDE 60 52 66 127
GENERLAC 60 59 66 216
ADVAIR DISKUS 58 45 69 46
LEVOFLOXACIN 58 43 69 75
AGGRENOX 57 54 71 253
SPIRONOLACTONE 57 44 71 77
NYSTATIN-TRIAMCINOLONE 57 53 71 190
NEXIUM 57 49 71 41
OXYBUTYNIN CHLORIDE 56 52 75 128
FENTANYL 55 51 S2 76 105
RISPERIDONE 55 42 76 43
ALLOPURINOL 54 52 78 49
PLAVIX 54 45 78 47
PROMETHAZINE HCL 53 41 R 80 149
NYSTOP 51 47 81 186
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 15, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.